1. Home
  2. NVAX vs SPNS Comparison

NVAX vs SPNS Comparison

Compare NVAX & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

SPNS

Sapiens International Corporation N.V. (Cayman Islands)

HOLD

Current Price

$43.32

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
SPNS
Founded
1987
1982
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
2.4B
IPO Year
1995
1992

Fundamental Metrics

Financial Performance
Metric
NVAX
SPNS
Price
$6.87
$43.32
Analyst Decision
Hold
Hold
Analyst Count
9
3
Target Price
$10.78
$31.33
AVG Volume (30 Days)
3.9M
397.1K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
1.39%
EPS Growth
N/A
N/A
EPS
2.07
1.15
Revenue
$1,064,651,000.00
$564,331,000.00
Revenue This Year
$58.91
$8.80
Revenue Next Year
N/A
$6.98
P/E Ratio
$3.34
$37.67
Revenue Growth
20.27
4.71
52 Week Low
$5.01
$23.69
52 Week High
$11.55
$43.36

Technical Indicators

Market Signals
Indicator
NVAX
SPNS
Relative Strength Index (RSI) 44.01 68.47
Support Level $6.56 $43.27
Resistance Level $7.03 $43.36
Average True Range (ATR) 0.25 0.09
MACD 0.08 -0.00
Stochastic Oscillator 81.33 91.12

Price Performance

Historical Comparison
NVAX
SPNS

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Share on Social Networks: